(PharmaNewsWire.Com, September 20, 2017 ) North America has the largest market share for liver cancer diagnostics and therapeutics market. This is due to technological innovations in cancer treatment devices.
With advancement in technology, novel drugs are being developed which work in a different way from usual chemotherapy drugs, by targeting precise parts of cancer cells or their neighbouring environment. Treating cancer is still not easy because disease symptoms generally appear in the late stage of the disease, resulting in a low diagnosis rate that in turn disturbs the patient volume available for treatment.
Technological developments, for instance non-invasive radiation therapy and rising incidence of cancer are key drivers for the North America lung cancer therapeutic market. Moreover, increasing government support and funding for research and development field has promoted the market growth. On the other hand, high costs associated with research activities and the expiry of copyrights of some bestseller drugs are obstructing the growth of the market.
The North America liver cancer therapeutics market is segmented on the basis of type into primary, secondary and benign liver growths. On the basis of therapeutics market is bifurcated into hepatocellular carcinoma, Cholangio carcinoma, Hepatoblastoma and targeted therapy. By end-users the market is divided amongst pediatrics and adults. Hepatocellular Carcinoma is the largest segment for therapeutics type due to the high prevalence of this type of liver cancer among people.
Based on geography the market is analysed under various regions namely, USA and Canada. US leads the North America region market due to high number of cancer cases in US which is augmenting the liver cancer therapeutics market for the country.
Some of the key contributors in the industry include Alnylam Pharmaceuticals Inc., ImClone Systems Inc., Onyx Pharmaceuticals Inc., F. Hoffmann-La Roche Ltd., Pfizer Inc., ArQule Inc., Jennerex Biotherapeutics Inc., Celsion Corp., Bayer Schering Pharma AG, 4SC AG, and Bristol-Myers Squibb Company.
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
